本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akari Therapeutics PLC

1.12
+0.02502.29%
成交量:1.28万
成交额:1.42万
市值:3,587.67万
市盈率:-1.06
高:1.13
开:1.10
低:1.09
收:1.09
数据加载中...
2019/06/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/03/01

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/02/27

SEC问询函

[Cover]Correspondence
2019/02/14

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/02/11

SEC问询函

[Cover]Correspondence
2018/12/06

SEC问询函

[Cover]Correspondence
2018/11/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]